Development of a Highly Productive and Scalable Plasmid DNA Production Platform
- 1 January 2006
- journal article
- Published by Wiley in Biotechnology Progress
- Vol. 22 (5) , 1335-1345
- https://doi.org/10.1021/bp060046h
Abstract
With the applications of DNA vaccines extending from infectious diseases to cancer, achieving the most efficient, reproducible, robust, scalable, and economical production of clinical grade plasmid D...Keywords
This publication has 55 references indexed in Scilit:
- DNA vaccines: Successes and limitations in cancer and infectious diseaseJournal of Cellular Biochemistry, 2006
- The application of multi-parameter flow cytometry to the study of recombinant Escherichia coli batch fermentation processesJournal of Industrial Microbiology & Biotechnology, 2004
- Combined transcriptome and proteome analysis of Escherichia coli during high cell density cultureBiotechnology & Bioengineering, 2003
- Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunityNature, 2002
- DNA Vaccines: Immunology, Application, and OptimizationAnnual Review of Immunology, 2000
- Use of a glycerol-limited, long-term chemostat for isolation of Escherichia coli mutants with improved physiological propertiesMicrobiology, 1997
- Cell cycle characteristics and changes in membrane potential during growth of Escherichia coli as determined by a cyanine fluorescent dye and flow cytometryJournal of Microbiological Methods, 1996
- Metabolic load and heterologous gene expressionBiotechnology Advances, 1995
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990
- Escherichia coli growth and plasmid copy numbers in continuous cultivationsBiotechnology Letters, 1989